van Es Charles 4
4 · Vita Coco Company, Inc. · Filed Mar 18, 2026
Research Summary
AI-generated summary of this filing
Vita Coco (COCO) CCO Charles van Es Sells 2,000 Shares
What Happened
Charles van Es, Chief Commercial Officer of Vita Coco Company, Inc. (COCO), sold 2,000 shares of common stock on March 16, 2026 at $57.98 per share, generating proceeds of $115,960. The sale is reported as transaction code S (sale) and was effected pursuant to a Rule 10b5-1 trading plan.
Key Details
- Transaction date: 2026-03-16; Price: $57.98 per share; Shares sold: 2,000; Proceeds: $115,960.
- Method: Open market or private sale (reported as open market/private sale).
- Plan/footnote: Sale effected under a Rule 10b5-1 trading plan (Footnote F1).
- Shares owned after transaction: Not specified in the provided filing summary.
- Filing: Form 4 filed 2026-03-18 for the 3/16/2026 transaction (appears timely based on the filing date).
- Additional footnotes in the filing note various stock option grants and vesting schedules (F2–F8); notably, a performance-based option vested for 14,025 shares on February 20, 2026 (F5).
Context
A sale under a 10b5-1 plan typically reflects a pre-established trading arrangement and is generally considered routine—such transactions do not, by themselves, indicate management’s current view of the company’s prospects. The filing also includes multiple footnotes about option grants and vesting schedules; those items are separate disclosures and do not necessarily relate to this particular sale.
Insider Transaction Report
- Sale
Common Stock
[F1]2026-03-16$57.98/sh−2,000$115,960→ 79,691 total
- 53,750
Non-Qualified Stock Option (Right to Buy)
[F2]Exercise: $10.18Exp: 2030-02-10→ Common Stock (53,750 underlying) - 27,300
Non-Qualified Stock Option (Right to Buy)
[F2]Exercise: $10.18Exp: 2031-01-11→ Common Stock (27,300 underlying) - 58,043
Non-Qualified Stock Option (Right to Buy)
[F3]Exercise: $15.00Exp: 2031-10-21→ Common Stock (58,043 underlying) - 42,980
Non-Qualified Stock Option (Right to Buy)
[F4]Exercise: $15.36Exp: 2032-08-15→ Common Stock (42,980 underlying) - 14,025
Non-Qualified Stock Option (Right to Buy)
[F5]Exercise: $16.91Exp: 2033-03-10→ Common Stock (14,025 underlying) - 14,205
Non-Qualified Stock Option (Right to Buy)
[F6]Exercise: $16.91Exp: 2033-03-10→ Common Stock (14,205 underlying) - 8,746
Non-Qualified Stock Option (Right to Buy)
[F7]Exercise: $26.18Exp: 2034-03-04→ Common Stock (8,746 underlying) - 13,218
Non-Qualified Stock Option (Right to Buy)
[F8]Exercise: $33.36Exp: 2035-03-04→ Common Stock (13,218 underlying)
Footnotes (8)
- [F1]The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The stock option is fully vested and currently exercisable.
- [F3]The stock option vests in four equal annual installments beginning on November 27, 2022.
- [F4]The stock option vests in three equal annual installments beginning on August 15, 2025.
- [F5]The stock option is eligible to vest if certain performance conditions are met by the target date for the applicable performance condition(s) and expire if the performance conditions are not met by the final target date. The performance conditions applicable were timely satisfied, resulting in vesting of the option as to 14,025 shares on February 20, 2026.
- [F6]The stock options vest in four annual equal installments beginning on March 10, 2024.
- [F7]The stock option vests in four equal annual installments beginning on March 4, 2025.
- [F8]The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.